CME/CE

Host: Mikhail Kosiborod, MD Despite evidence and guideline recommendations, renin-angiotensin-aldosterone system inhibitor (RAASi) therapy tends to be used suboptimally among patients with heart failure (HF), particularly in patients with chronic kidney disease (CKD). What are the real-world factors that influence RAASi treatment decisions in patients with HF who have or are at risk for hyperkalem...

Host: Mikhail Kosiborod, MD Despite evidence and guideline recommendations, renin-angiotensin-aldosterone system inhibitor (RAASi) therapy tends to be used suboptimally among patients with heart failure (HF), particularly in patients with chronic kidney disease (CKD). What are the real-world factors that influence RAASi treatment decisions in patients with HF who have or are at risk for hyperkalem...

Guest: David P. Hudesman, MD Please note: This activity is no longer available for continuing education credit. It is estimated that only 20% to 30% of patients with Crohn’s disease (CD) have a non-progressive or indolent course. While most patients with CD present with non-penetrating or non-stricturing disease, 50% of patients develop intestinal complications within 20 years of diagnosis. In thi...

Guest: Anita Afzali MD, MPH, FACG, AGAF Please note: This activity is no longer available for continuing education credit. The management of IBD remains challenging, owing to variable clinical presentations and ever-changing therapeutic options. In this program, Dr. Anita Afzali presents the case of a newly diagnosed patient with IBD, highlighting the importance of prompt diagnosis and aggressive...

Guest: David P. Hudesman, MD Please note: This activity is no longer available for continuing education credit. It is estimated that only 20% to 30% of patients with Crohn’s disease (CD) have a non-progressive or indolent course. While most patients with CD present with non-penetrating or non-stricturing disease, 50% of patients develop intestinal complications within 20 years of diagnosis. In thi...

Guest: Anita Afzali MD, MPH, FACG, AGAF Please note: This activity is no longer available for continuing education credit. The management of IBD remains challenging, owing to variable clinical presentations and ever-changing therapeutic options. In this program, Dr. Anita Afzali presents the case of a newly diagnosed patient with IBD, highlighting the importance of prompt diagnosis and aggressive...

Guest: Peter A. Lio, MD Guest: Mark Boguniewicz, MD Guest: Eric Simpson, MD, MCR Please note: This activity is no longer available for continuing education credit. Infants have the highest incidence of atopic dermatitis in the US but the fewest treatment options. This is a case a doctor submitted about a baby who is refractory to multiple oral and topical treatments. A multidisciplinary panel disc...

Guest: Peter A. Lio, MD Guest: Mark Boguniewicz, MD Guest: Eric Simpson, MD, MCR Please note: This activity is no longer available for continuing education credit. A multidisiplinary panel is presented with a highly allergic, extremely refractory patient with atopic dermatitis. Her dermatologist wants to take the next step and start her on a biologic, but she's worried about the patient's occular...

Guest: Peter A. Lio, MD Guest: Mark Boguniewicz, MD Guest: Eric Simpson, MD, MCR Please note: This activity is no longer available for continuing education credit. Tune in as a multidisciplinary panel discusses a clinician's question about the appropriateness of combining two biologics in a very young child with several atopic diseases.

Guest: Peter A. Lio, MD Guest: Mark Boguniewicz, MD Guest: Eric Simpson, MD, MCR Please note: This activity is no longer available for continuing education credit. Infants have the highest incidence of atopic dermatitis in the US but the fewest treatment options. This is a case a doctor submitted about a baby who is refractory to multiple oral and topical treatments. A multidisciplinary panel disc...

Guest: Peter A. Lio, MD Guest: Mark Boguniewicz, MD Guest: Eric Simpson, MD, MCR Please note: This activity is no longer available for continuing education credit. A multidisiplinary panel is presented with a highly allergic, extremely refractory patient with atopic dermatitis. Her dermatologist wants to take the next step and start her on a biologic, but she's worried about the patient's occular...

Guest: Peter A. Lio, MD Guest: Mark Boguniewicz, MD Guest: Eric Simpson, MD, MCR Please note: This activity is no longer available for continuing education credit. Tune in as a multidisciplinary panel discusses a clinician's question about the appropriateness of combining two biologics in a very young child with several atopic diseases.

Host: Joseph K. Han, MD Please note: This activity is no longer available for continuing education credit. Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with significant morbidity and negatively impacts quality of life. The good news is that biologic therapies targeting type 2 inflammatory pathways provide additional treatment options for CRSwNP. However, clinicians not only need...

Host: Anne O'Donnell, MD Guest: Robert "Brinkley" Sewell Please note: This activity is no longer available for continuing education credit. The successful management of nontuberculous mycobacteria lung disease (NTM-LD) remains challenging owing to the need for long-term treatment, the ongoing risks of adverse drug reactions, and the potential for nonadherence. These factors undersco...

Host: Anne O'Donnell, MD Guest: Patrick Flume, MD Please note: This activity is no longer available for continuing education credit. Nontuberculous mycobacteria lung disease (NTM-LD) is a relatively uncommon condition, although its prevalence is rising. In this interactive CME activity, Drs. Anne O’Donnell and Patrick Flume review two patient cases to demonstrate how clinicians can maintain a...

Host: Joseph K. Han, MD Please note: This activity is no longer available for continuing education credit. Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with significant morbidity and negatively impacts quality of life. The good news is that biologic therapies targeting type 2 inflammatory pathways provide additional treatment options for CRSwNP. However, clinicians not only need...

Host: Anne O'Donnell, MD Guest: Robert "Brinkley" Sewell Please note: This activity is no longer available for continuing education credit. The successful management of nontuberculous mycobacteria lung disease (NTM-LD) remains challenging owing to the need for long-term treatment, the ongoing risks of adverse drug reactions, and the potential for nonadherence. These factors undersco...

Host: Anne O'Donnell, MD Guest: Patrick Flume, MD Please note: This activity is no longer available for continuing education credit. Nontuberculous mycobacteria lung disease (NTM-LD) is a relatively uncommon condition, although its prevalence is rising. In this interactive CME activity, Drs. Anne O’Donnell and Patrick Flume review two patient cases to demonstrate how clinicians can maintain a...

Host: Peter A. Lio, MD Guest: Eric Simpson, MD, MCR Guest: Mark Boguniewicz, MD Please note: This activity is no longer available for continuing education credit. “I begged my doctor for something else – there had to be something else,” Pam. For over 50 years, Pam suffered with uncontrolled moderate-to-severe atopic dermatitis (AD). She experienced the evolution of treatment strategies over the co...

Host: Peter A. Lio, MD Guest: Eric Simpson, MD, MCR Guest: Mark Boguniewicz, MD Please note: This activity is no longer available for continuing education credit. “I begged my doctor for something else – there had to be something else,” Pam. For over 50 years, Pam suffered with uncontrolled moderate-to-severe atopic dermatitis (AD). She experienced the evolution of treatment strategies over the co...

Host: Shira Johnson, MD Guest: Amy L. Olson, MD, MSPH Guest: Jeffrey Swigris, DO, MS Guest: Katherine Rosen, RN, MSN, ANP-C Please note: This activity is no longer available for continuing education credit. This discussion highlights the diagnosis of and treatment approach for interstitial pneumonia with autoimmune features (IPAF).

Host: Shira Johnson, MD Guest: Amy L. Olson, MD, MSPH Guest: Jeffrey Swigris, DO, MS Guest: Katherine Rosen, RN, MSN, ANP-C Please note: This activity is no longer available for continuing education credit. This discussion highlights the challenges associated with progressive-fibrosing ILD diagnosis, explains management differences for connective tissue disease-associated ILD, and reviews therapeu...

Host: Shira Johnson, MD Guest: Amy L. Olson, MD, MSPH Guest: Jeffrey Swigris, DO, MS Guest: Katherine Rosen, RN, MSN, ANP-C Please note: This activity is no longer available for continuing education credit. This discussion highlights the diagnosis of and treatment approach for interstitial pneumonia with autoimmune features (IPAF).

Host: Shira Johnson, MD Guest: Amy L. Olson, MD, MSPH Guest: Jeffrey Swigris, DO, MS Guest: Katherine Rosen, RN, MSN, ANP-C Please note: This activity is no longer available for continuing education credit. This discussion highlights the challenges associated with progressive-fibrosing ILD diagnosis, explains management differences for connective tissue disease-associated ILD, and reviews therapeu...

Host: Eric H. Kraut, MD Hemophilia A is a rare bleeding disorder caused by deficiency of clotting factor VIII. The current standard of care for patients with severe hemophilia A centers on replacement therapy with factor VIII concentrate, either on demand when bleeding occurs or prophylactically (replacement therapy). Potential complications from replacement therapy include the development of inhi...